Legal & General Group
ORGO icon

Legal & General Group’s Organogenesis Holdings ORGO Stock Holding History

Legal & General Group’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Hold
6,087
– – ﹤0.01% 3227
2026
Q1 		$14.4K Sell
6,087
-1,054
-15% -$3.65K ﹤0.01% 3088
2025
Q4 		$37K Sell
7,141
-337
-5% -$1.63K ﹤0.01% 2807
2025
Q3 		$31.6K Hold
7,478
– – ﹤0.01% 2870
2025
Q2 		$27.4K Buy
7,478
+1,189
+19% +$4.43K ﹤0.01% 2884
2025
Q1 		$27.2K Hold
6,289
– – ﹤0.01% 2837
2024
Q4 		$20.1K Hold
6,289
– – ﹤0.01% 3020
2024
Q3 		$18K Hold
6,289
– – ﹤0.01% 3088
2024
Q2 		$17.6K Hold
6,289
– – ﹤0.01% 3079
2024
Q1 		$17.9K Hold
6,289
– – ﹤0.01% 3011
2023
Q4 		$25.7K Sell
6,289
-68,123
-92% -$191K ﹤0.01% 2935
2023
Q3 		$236K Buy
74,412
+67,079
+915% +$213K ﹤0.01% 2683
2023
Q2 		$24.3K Sell
7,333
-5,427
-43% -$16K ﹤0.01% 3025
2023
Q1 		$27.2K Sell
12,760
-155,199
-92% -$383K ﹤0.01% 2983
2022
Q4 		$452K Buy
167,959
+3,903
+2% +$11.4K ﹤0.01% 2363
2022
Q3 		$531K Buy
164,056
+16,034
+11% +$72.5K ﹤0.01% 2330
2022
Q2 		$723K Buy
148,022
+6,374
+4% +$39.2K ﹤0.01% 2255
2022
Q1 		$1.08M Buy
141,648
+1,513
+1% +$11.7K ﹤0.01% 2218
2021
Q4 		$1.29M Buy
140,135
+6,078
+5% +$64.6K ﹤0.01% 2182
2021
Q3 		$1.91M Buy
134,057
+31,151
+30% +$484K ﹤0.01% 2044
2021
Q2 		$1.71M Buy
102,906
+100,239
+3,758% +$1.87M ﹤0.01% 2043
2021
Q1 		$49K Buy
2,667
+135
+5% +$1.83K ﹤0.01% 2818
2020
Q4 		$19K Hold
2,532
– – ﹤0.01% 3118
2020
Q3 		$10K Sell
2,532
-852
-25% -$3.36K ﹤0.01% 3237
2020
Q2 		$13K Buy
3,384
+1,203
+55% +$4.34K ﹤0.01% 3240
2020
Q1 		$7K Hold
2,181
– – ﹤0.01% 3222
2019
Q4 		$10K Buy
2,181
+430
+25% +$2.73K ﹤0.01% 3294
2019
Q3 		$11K Hold
1,751
– – ﹤0.01% 3256
2019
Q2 		$13K Buy
+1,751
New +$12.9K ﹤0.01% 3314

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Legal & General Group's ORGO Position: Q2 2026 in Review

Legal & General Group held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 6,087 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3227.

Legal & General Group first reported a position in ORGO in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.91M in Q3 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Legal & General Group held 6,087 shares of Organogenesis Holdings worth $14.8K as of Q2 2026.
  • Legal & General Group left its Organogenesis Holdings share count unchanged in Q2 2026.
  • Organogenesis Holdings made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3227 holding.
  • Legal & General Group first reported a position in Organogenesis Holdings in Q2 2019 and has held it in 29 quarters since.
  • Legal & General Group's Organogenesis Holdings position peaked at $1.91M in Q3 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.